Biomarker Discovery in Alzheimer’s and Neurodegenerative Diseases using Nucleic Acid-Linked Immuno-Sandwich Assay Nicholas J. Ashton et al. Background Recent advancements...
Alzheimer’s Disease
Head-to-head comparison of leading blood tests for Alzheimer’s disease pathology Suzanne Schindler et al. This study compared leading commercial...
“In vivo validation of late-onset Alzheimer’s disease genetic risk factors.” Michael Sasner, et al. – The Jackson Laboratory. Background:...
“Identification of Rare Damaging Missense and Loss of Function Variants in GWAS Loci Using Genome Sequencing Data from Two...
“Remote and unsupervised digital memory assessments can reliably detect cognitive impairment in Alzheimer’s disease.” David Berron, et al. –...
“Psychotic symptoms are associated with elevated tau PET signal in the amygdala independent of Alzheimer’s disease clinical severity and...
“Somatic cancer driver mutations are enriched and associated with inflammatory states in Alzheimer’s disease microglia.” August Yue Huang, et...
“Rare genetic variation in Fibronectin 1 (FN1) protects against APOEe4 in Alzheimer’s disease.” Prabesh Bhattarai, et al. – Columbia...
“Noradrenergic signaling controls Alzheimer’s disease pathology via activation of microglial β2 adrenergic receptors.” Linh Le, et al. – University...
“P-tau217 and other blood biomarkers of dementia: variation with time of day.” Ciro della Monica, et al. – University...